Novoste Guiding Catheter
Novoste
FDA Clearance Information
The Novoste guiding catheter was cleared through the FDA 510(k) pathway on April 24, 1991. It is manufactured by Novoste and classified as a Class 2 device under product code DQY.
What It Is
FDA-Cleared Indications
- Percutaneous catheter use for access to, navigation through, or delivery of devices within the vascular system, consistent with product code DQY.
Clinical Applications
- Use as a guiding catheter during selected percutaneous vascular interventions.
- Navigation through an arterial or venous access route to position another catheter or endovascular device.
- Use in procedures requiring fluoroscopic guidance and controlled catheter advancement.
Reported off-label uses
- Use as part of coronary brachytherapy procedures has been described for treatment of in-stent restenosis, but this use should be confirmed against the device-specific labeling and current availability.
- Use through transradial access has been reported in clinical practice for selected coronary interventions.
Off-label use: these uses are reported in practice or the literature but are not part of the FDA-cleared indications. Physicians may use a cleared device off-label based on their medical judgment; the manufacturer may not promote off-label uses.
Evidence Summary
Reported Outcomes
Safety Profile
Evidence Limitations
Practical Considerations
- Confirm the catheter's labeled size, length, tip configuration, guidewire compatibility, and maximum pressure before use.
- Use fluoroscopic imaging and standard sterile technique; advance without force to reduce the risk of vessel injury, dissection, or perforation.
- Compatibility with other catheters, wires, radiation-delivery systems, contrast agents, and access sheaths must be checked before the procedure.
- MRI safety depends on the exact model and whether the catheter contains metallic or other MR-conditional components; do not assume it is MRI safe without current manufacturer labeling.
- The device is generally intended for single-use procedural application; inspect packaging and device integrity before use and follow the labeled contraindications and warnings.
Procedures that use this device
Frequently Asked Questions
What are the clinical indications for Novoste guiding catheter?
The Novoste guiding catheter is indicated for use in coronary brachytherapy, particularly for treating in-stent restenosis.
What outcomes have been reported in clinical studies?
Studies report successful dilation of lesions and completion of procedures without additional stenting, demonstrating effective use in coronary brachytherapy.
What complications have been reported?
Reported complications include potential dosimetric effects from metallic guide wires, though specific adverse events related to the catheter were not detailed.